Analysis of neutralizing antibodies against hepatitis C virus in patients who were treated with pegylated-interferon plus ribavirin

Kobe Journal of Medical Sciences

Volumn 56, Issue 2, 2010, Pages

  Sasayama, Mikiko ^a   Deng, Lin ^a   Kim, Soo Ryang ^b   Ide, Yoshi Hiro ^a   Shoji, Ikuo ^a   Hotta, Hak ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE ASAHI HOSPITAL   (Japan)

Author keywords

Hepatitis C virus; Neutralizing antibody; Pegylated interferon plus ribavirin; Treatment outcome

Indexed keywords

HEPATITIS C ANTIBODY; NEUTRALIZING ANTIBODY; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ANTIBODY RESPONSE; ANTIBODY SCREENING; ANTIBODY TITER; ANTIVIRAL THERAPY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; CROSS REACTION; DISEASE ASSOCIATION; DRUG RESPONSE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; NONHUMAN; RELAPSE; VIROLOGY; VIRUS STRAIN; VIRUS TYPING;

ANTIBODIES, NEUTRALIZING; ANTIVIRAL AGENTS; CELL LINE; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; POLYETHYLENE GLYCOLS; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME;

EID: 77958539679     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bartosch, B., Bukh, J., Meunier, J. C., Granier, C., Engle, R. E., Blackwelder, W. C., Emerson, S. U., Cosset, F. L., and Purcell, R. H. 2003. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci U S A. 100: 14199-204.
2. Baumert, T. F., Wellnitz, S., Aono, S., Satoi, J., Herion, D., Tilman, G. J., Pape, G. R., Lau, J. Y., Hoofnagle, J. H., Blum, H. E., and Liang, T. J. 2000. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C. Hepatology 32: 610-17.
3. Blight, K. J., MaKeating, J. A., and Rice, C. M. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76: 13001-13014.
4. Bowen, D. G., and Walker, C. M. 2005. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436: 946-52.
5. Bungyoku, Y., Shoji, I., Makine, T., Adachi, T., Hayashida, K., Nagano-Fujii, M., Ide, YH., Deng, L., and Hotta, H. 2009. Efficient prodection of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells. J Gen Virol. 90: 1681-91.
6. Caetano, J., Martinho, A., Paiva, A., Pais, B., Valente, C., and Luxo, C. 2008. Differences in hepatitis C virus (HCV)-specific CD8 T-cell phenotype during egylated alpha interferon and ribavirin treatment are related to response to antiviral therapy in patients chronically infected with HCV. J Virol. 82: 7567-77.
7. Cramp, M. E., Rossol, S., Chokshi, S., Carucci, P., Williams, R., and Naoumov, N. V. 2000. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin reatment in chronic hepatitis C. Gastroenterology. 118: 346-55.
8. El-Shamy, A., Sasayama, M., Nagano-Fujii, M., Sasase, N., Imoto, S., Kim, S. R., and Hotta, H. 2007. Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera. Microbiol Immunol. 51: 471-82.
9. El-Shamy, A., Nagano-Fujii, M., Sasase, N., Imoto, S., Kim, S. R., and Hotta, H. 2008. Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy. Hepatology. 48: 38-47.
10. Lavillette, D., Morice, Y., Germanidis, G., Donot, P., Soulier, A., Pagkalos, E., Sakellariou, G., Intrator, L., Bartosch, B., Pawlotsky, JM., and Cosset, FL. 2005. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J Virol. 79: 6023-34.
11. Lindenbach, B. D, Evans, M. J., Syder, A. J., Wölk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R., McKeating, J. A., and Rice, C. M. 2005. Complete replication of hepatitis C virus in cell culture. Science. 309: 623-626.
12. Moradpour, D., Francois P. F., and Rice, C. M. 2007. Replication of hepatitis C virus. Nat. Rev. Microbiol. 5: 453-63.
13. Youn, J. W., Park, S. H., Lavillette, D., Cosset, F. L., Yang, S. H., Lee, C. G., Jin, H. T., Kim, C. M., Shata, M. T., Lee, D. H., Pfahler, W., Prince, A. M., and Sung, Y. C. 2005. Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee. Hepatology. 42: 1429-36.
14. Takaki, A., Wiese, M., Maertens, G., Depla, E., Seifert, U., Liebetrau, A., Miller, J. L., Manns, M. P., and Rehermann, B. 2000. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 6: 578-82.
15. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H. G., Mizokami, M., Bartenschlager, R., and Liang, T. J. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med. 2005 11: 791-6.
16. Youn, J. W., Park, S. H., Lavillette, D., Cosset, F. L., Yang, S. H., Lee, C. G., Jin, H. T., Kim, C. M., Shata, M. T., Lee, D. H., Pfahler, W., Prince, A. M., and Sung, Y. C. 2005. Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee. Hepatology. 42: 1429-36.